Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Jiexuan Chen und 23 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Proteolysis, Small Molecule Libraries. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The tedious synthesis and limited throughput biological evaluation remain a great challenge for discovering new proteolysis targeting chimera (PROTAC). To rapidly identify potential PROTAC lead compounds, we report a platform named Auto-RapTAC. Based on the modular characteristic of the PROTAC molecule, a streamlined workflow that integrates lab automation with "click chemistry" joint building-block libraries was constructed. This facilitates the autonomous generation of a variety of PROTACs, each with distinct linkers and E3 ligase ligands, all stored in biocompatible solutions. The ready-for-screening (R4S) approach, when paired with fluorescence-based assays, enables the efficient assessment of the PROTAC degradation activity in a high-throughput manner. To further test the capability of the platform, we identify six new PROTACs that target CDK2, CDK12, and BCL6 within a mere 8-day time frame for each target. In all, this platform could find broad application not only in discovering new PROTACs but also in the rapid development of novel heterobifunctional modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- Center of Safety Evaluation and Research, School of Pharmacy, Hangzhou Medical College, Hangzhou 310013, China.
- College of Computer Science and Technology, Zhejiang University, Hangzhou 310058, China.
- National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310024, China.
ORCID-Profile: Shenxin Zeng, Xiaowu Dong, Jinxin Che
Förderung
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Wu, M., Mo, J., Hong, J., Wang, W., Jin, Y., Mao, X., Liao, X., Li, K., Yu, X., Chen, S., Zeng, S., Huang, W., Xu, H., Wu, J., Cao, J., Zhou, Y., Ying, M., Zhu, C., …, & Che, J. (2025). Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02438
Vancouver
Chen J, Wu M, Mo J, Hong J, Wang W, Jin Y, et al. Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02438
BibTeX
@article{Chen2025,
author = {Chen, Jiexuan and Wu, Mingfei and Mo, Jun and Hong, Ju and Wang, Wei and Jin, Yuheng and Mao, Xinfei and Liao, Xueyan and Li, Kailin and Yu, Xiaoli and Chen, Sikang and Zeng, Shenxin and Huang, Wenhai and Xu, Hongxia and Wu, Jian and Cao, Ji and Zhou, Yubo and Ying, Meidan and Zhu, Chengliang and He, Qiaojun and Zhang, Bo and Lin, Nengming and Dong, Xiaowu and Che, Jinxin},
title = {Auto-RapTAC: A Versatile and Sustainable Platform for the Automated Rapid Synthesis and Evaluation of PROTAC},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02438}
}
EUVIMED